BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37540951)

  • 21. Exploiting the biological efficacy of benzimidazole based Schiff base complexes with l-Histidine as a co-ligand: Combined molecular docking, DNA interaction, antimicrobial and cytotoxic studies.
    Kumaravel G; Ponya Utthra P; Raman N
    Bioorg Chem; 2018 Apr; 77():269-279. PubMed ID: 29421702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel pyrazole-based COX-2 inhibitors as potential anticancer agents: Design, synthesis, cytotoxic effect against resistant cancer cells, cell cycle arrest, apoptosis induction and dual EGFR/Topo-1 inhibition.
    Halim PA; Sharkawi SMZ; Labib MB
    Bioorg Chem; 2023 Feb; 131():106273. PubMed ID: 36444790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Aldimine-Type Schiff Bases of 4-Amino-5-[(3,4,5-trimethoxyphenyl)methyl]-1,2,4-triazole-3-thione/thiol: Docking Study, Synthesis, Biological Evaluation, and Anti-Tubulin Activity.
    Ameri A; Khodarahmi G; Hassanzadeh F; Forootanfar H; Hakimelahi GH
    Arch Pharm (Weinheim); 2016 Aug; 349(8):662-81. PubMed ID: 27320785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
    He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
    Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents.
    Kadhim ZY; Alqaraghuli HGJ; Abd MT
    Anticancer Agents Med Chem; 2021; 21(17):2397-2406. PubMed ID: 33797379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
    Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
    Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of matrine-dithiocarbamate hybrids as potential anticancer agents.
    Zhang MW; He Y; Wei MX
    Eur J Med Chem; 2023 Jun; 254():115375. PubMed ID: 37084600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
    Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
    Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in silico study of the biological activity of tetradentate Schiff base copper(II) complexes with ethylenediamine-bridge.
    Mijatović A; Gligorijević N; Ćoćić D; Spasić S; Lolić A; Aranđelović S; Nikolić M; Baošić R
    J Inorg Biochem; 2023 Jul; 244():112224. PubMed ID: 37080139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiproliferative Properties of 7,8-Ethylene Diamine Chelator-Lipophilic Fluoroquinolone Derivatives Against Colorectal Cancer Cell Lines.
    Khaleel S; Al-Hiari Y; Kasabri V; Haddadin R; Albashiti R; Al-Zweri M; Bustanji Y
    Anticancer Agents Med Chem; 2022; 22(5):1012-1028. PubMed ID: 34165411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on free radical scavenging, cancer cell antiproliferation, and calf thymus DNA interaction of Schiff bases.
    da Silva CM; Silva MM; Reis FS; Ruiz ALTG; de Carvalho JE; Santos JCC; Figueiredo IM; Alves RB; Modolo LV; de Fátima Â
    J Photochem Photobiol B; 2017 Jul; 172():129-138. PubMed ID: 28549321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schiff base-nickel, palladium, and platinum complexes derived from N-cyclohexyl hydrazine carbothioamide and 3-hydroxy-4-methoxybenzaldehyde: Selective antiproliferative and proapoptotic effects against colorectal carcinoma.
    Arafath MA; Al-Suede FSR; Adam F; Al-Juaid S; Khadeer Ahamed MB; Majid AMSA
    Drug Dev Res; 2019 Sep; 80(6):778-790. PubMed ID: 31215682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular docking study, synthesis and biological evaluation of Schiff bases as Hsp90 inhibitors.
    Dutta Gupta S; Snigdha D; Mazaira GI; Galigniana MD; Subrahmanyam CV; Gowrishankar NL; Raghavendra NM
    Biomed Pharmacother; 2014 Apr; 68(3):369-76. PubMed ID: 24486109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.
    Hajipour F; Mahdavinia M; Fereidoonnezhad M
    Anticancer Agents Med Chem; 2022; 22(6):1149-1158. PubMed ID: 34259151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Design, Spectroscopic, DFT, Pharmacological, and Molecular Docking Studies of Novel Ruthenium(III)-Schiff Base Complex: An Inhibitor of Progression in HepG2 Cells.
    Noureldeen AFH; Aziz SW; Shouman SA; Mohamed MM; Attia YM; Ramadan RM; Elhady MM
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and molecular docking study of some 2-((7-chloroquinolin-4-yl) amino) benzohydrazide Schiff bases as potential Eg5 inhibitory agents.
    Kavalapure RS; Alegaon SG; Venkatasubramanian U; Priya AS; Ranade SD; Khanal P; Mishra S; Patil D; Salve PS; Jalalpure SS
    Bioorg Chem; 2021 Nov; 116():105381. PubMed ID: 34601297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation.
    Reda Aouad M; Almehmadi MA; Faleh Albelwi F; Teleb M; Tageldin GN; Abu-Serie MM; Hagar M; Rezki N
    Bioorg Chem; 2022 Jul; 124():105816. PubMed ID: 35489270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Thiazolyl-triazole Schiff Bases: Synthesis and Evaluation of the Anti-Candida Potential.
    Stana A; Enache A; Vodnar DC; Nastasă C; Benedec D; Ionuț I; Login C; Marc G; Oniga O; Tiperciuc B
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27879678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, structure and antiproliferative and optical activities of two new biphenyl-derived Schiff bases.
    Tan XJ; Zhang LY; Sun YK; Zhou XM
    Acta Crystallogr C Struct Chem; 2019 Feb; 75(Pt 2):97-106. PubMed ID: 30720447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.